A

Accelerate Diagnostics
D

AXDX

1.19000
USD
0.08
(7.21%)
Market Closed
Volume
200
EPS
0
Div Yield
-
P/E
-0
Market Cap
29,802,148
Related Instruments
    BDX
    BDX
    -0.590
    (-0.26%)
    227.450 USD
    COO
    COO
    -0.180
    (-0.20%)
    88.490 USD
    DHR
    DHR
    2.150
    (1.03%)
    210.170 USD
    EW
    EW
    -1.380
    (-1.85%)
    73.300 USD
    H
    HOLX
    0.180
    (0.28%)
    64.510 USD
    ILMN
    ILMN
    -3.080
    (-3.17%)
    94.180 USD
    ISRG
    ISRG
    -15.37
    (-2.53%)
    591.50 USD
    MDT
    MDT
    2.000
    (2.27%)
    89.940 USD
    P
    PODD
    -5.82
    (-2.02%)
    282.56 USD
    RMD
    RMD
    -1.320
    (-0.57%)
    231.520 USD
    TMO
    TMO
    -5.71
    (-1.06%)
    532.28 USD
    More
News

Title: Accelerate Diagnostics

Sector: Healthcare
Industry: Medical Devices
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.